Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,523 | -18,276 | -26,457 | -83,440 | -29,365 |
| Depreciation Amortization | 4,772 | 4,608 | 4,273 | 4,254 | 2,551 |
| Accounts receivable | 2,091 | 188 | -3,099 | 25 | -1,133 |
| Other Working Capital | -27,158 | -6,893 | 13,479 | 27,246 | 1,124 |
| Other Operating Activity | 712 | 1,015 | 4,062 | 41,921 | -5,275 |
| Operating Cash Flow | $-26,106 | $-19,358 | $-7,742 | $-9,994 | $-32,098 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 384 | -259 | 62 | -146 | -106 |
| PPE Investments | -655 | -627 | -686 | -968 | -829 |
| Purchase Of Investment | -20,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 319 | 3 | 33 | -5 | -32 |
| Investing Cash Flow | $-19,952 | $-883 | $-591 | $-1,119 | $-967 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 9,542 | 19,681 |
| Debt Repayment | -215 | N/A | -4,752 | -10,961 | N/A |
| Common Stock Issued | 46,682 | N/A | N/A | N/A | 14 |
| Financing Cash Flow | $46,467 | $N/A | $-4,752 | $-1,419 | $19,695 |
| Exchange Rate Effect | 64 | 225 | -270 | 414 | 277 |
| Beginning Cash Position | 17,792 | 37,808 | 51,163 | 63,281 | 76,374 |
| End Cash Position | 18,265 | 17,792 | 37,808 | 51,163 | 63,281 |
| Net Cash Flow | $473 | $-20,016 | $-13,355 | $-12,118 | $-13,093 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,106 | -19,358 | -7,742 | -9,994 | -32,098 |
| Capital Expenditure | -655 | -627 | -686 | -971 | -849 |
| Free Cash Flow | -26,761 | -19,985 | -8,428 | -10,965 | -32,947 |